美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
36354 A V 2022/03/31 ITM PHARMA SOLUTIONS GMBH IQS-TS RECONSTITUTION MODULE
36865 A II 2022/03/31 GRANULES INDIA LTD OLMESARTAN MEDOXOMIL USP
36927 A II 2022/03/31 DR REDDYS LABORATORIES LTD SIPONIMOD HEMIFUMARATE
36928 A II 2022/03/31 DR REDDYS LABORATORIES LTD EMPAGLIFLOZIN (PRODUCT CODE: EGF8)
36931 A II 2022/03/31 MSN LABORATORIES PRIVATE LTD DRONEDARONE HYDROCHLORIDE USP
36933 A II 2022/03/31 DR REDDYS LABORATORIES LTD BEMPEDOIC ACID
36939 A II 2022/03/31 MSN LABORATORIES PRIVATE LTD ERTUGLIFLOZIN L-PYROGLUTAMIC ACID
36940 A IV 2022/03/31 MSN LIFE SCIENCES PRIVATE LTD CALCOBUTROL SODIUM
36946 A II 2022/03/31 NEULAND LABORATORIES LTD LINEZOLID USP (PROCESS-II)
36947 A II 2022/03/31 NEULAND LABORATORIES LTD ELAGOLIX SODIUM
36954 A II 2022/03/31 RAMDEV CHEMICAL PRIVATE LTD HYDROXYZINE PAMOATE USP
36963 A II 2022/03/31 METROCHEM API PRIVATE LTD ZINC SULFATE HEPTAHYDRATE USP
36964 A II 2022/03/31 METROCHEM API PRIVATE LTD ZINC CHLORIDE USP
36996 A II 2022/03/31 MSN LIFE SCIENCES PRIVATE LTD GADOBUTROL MONOHYDRATE USP
36999 A II 2022/03/31 MSN LIFE SCIENCES PRIVATE LTD DOLUTEGRAVIR SODIUM
37001 A III 2022/03/31 PRAVESHA INDUSTRIES PRIVATE LTD POLYPROPYLENE CONTAINERS
37015 A II 2022/03/31 MAITHRI DRUGS PRIVATE LTD OZANIMOD HYDROCHLORIDE
37026 A II 2022/03/31 GLENMARK LIFE SCIENCES LTD TAFAMIDIS MEGLUMINE
36767 A II 2022/03/31 MSN LABORATORIES PRIVATE LTD REVEFENACIN
36778 A II 2022/03/31 CIPLA LTD MIRABEGRON

数据库说明:

当前数据更新日期:2022年4月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2022 DrugFuture->U.S. FDA Drug Master Files